Brussels, 27/03/2006 (Agence Europe) - On 27 March, the European Commission published a warning that fakes of the medicine rimonabant are currently being sold via several websites. Rimonabant was developed by Sanofi-Adventis to treat obesity and related risk factors (cardiovascular risks and/or diabetes) and giving up smoking (clinical trials have not yet been completed on smoking). The medicine is still under evaluation by the European Medicines Agency (EMEA) and the drug will only receive...